|4Jan 24, 5:45 PM ET

Branning Todd P. 4

4 · Amneal Pharmaceuticals, Inc. · Filed Jan 24, 2019

Insider Transaction Report

Form 4
Period: 2019-01-22
Branning Todd P.
SVP, Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2019-01-22+80,38680,386 total
    Class A Common Stock (80,386 underlying)
  • Award

    Stock Option

    2019-01-22+163,666163,666 total
    Exercise: $12.44Exp: 2029-01-22Class A Common Stock (163,666 underlying)
Footnotes (3)
  • [F1]The option vests in four equal annual installments beginning on January 22, 2020.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning on January 22, 2020 and have no expiration date.

Documents

1 file
  • 4
    wf-form4_154836993308270.xmlPrimary

    FORM 4